Drug of the Day: Bupropion (Wellbutrin) — The Antidepressant That Breaks the Mold

Why Bupropion Deserves the Spotlight

In a world dominated by SSRIs, bupropion (brand name Wellbutrin) stands apart. It is the only widely prescribed antidepressant that works primarily through dopamine and norepinephrine, not serotonin. That distinction makes it a uniquely valuable tool in the psychiatric toolbox, and one of the most interesting drugs in modern psychopharmacology.

What Does Bupropion Treat?

FDA-Approved Indications:

- Major Depressive Disorder (MDD) — the primary indication, supported by multiple controlled trials

- Seasonal Affective Disorder (SAD) — approved for prevention of seasonal depressive episodes (Wellbutrin XL)

- Smoking Cessation — marketed under the brand name Zyban

Off-Label Uses:

Bupropion has a robust off-label life as well:

- ADHD in adults — leveraging its dopaminergic and noradrenergic activity

- Bipolar depression — with a notably low rate of manic switch compared to other antidepressants

- Depression in Parkinson's disease — where its dopaminergic action may be especially beneficial given the underlying dopamine deficiency

- Sexual dysfunction caused by SSRIs — often added as an adjunct to counteract this common side effect

- Weight management — bupropion is a component of the FDA-approved combination drug Contrave (naltrexone/bupropion) for chronic weight management

How Does It Work? The Dopamine and Norepinephrine Story

Bupropion is classified as a norepinephrine-dopamine reuptake inhibitor (NDRI). It blocks the reuptake transporters for dopamine (DA) and norepinephrine (NE), increasing the availability of these neurotransmitters in the synaptic cleft. Importantly, it has no meaningful effect on serotonin, which is what makes it so different from SSRIs and SNRIs.

Its active metabolite, hydroxybupropion, plays a critical role in its antidepressant activity and appears to be responsible for much of the drug's noradrenergic effects.

Why Do Dopamine and Norepinephrine Matter in Depression?

Depression is not just about feeling sad. It involves a constellation of symptoms — low motivation, inability to feel pleasure (anhedonia), fatigue, poor concentration, and psychomotor slowing. These symptoms map directly onto dopamine and norepinephrine circuits in the brain:

- Dopamine is the neurotransmitter of reward, motivation, and pleasure. The mesolimbic pathway (from the ventral tegmental area to the nucleus accumbens) drives reward processing. When this system is underactive, patients experience anhedonia — the hallmark inability to enjoy things they once loved. The mesocortical pathway (projecting to the prefrontal cortex) governs executive function, attention, and decision-making, which are often impaired in depression.

- Norepinephrine is the neurotransmitter of alertness, energy, and concentration. Noradrenergic neurons originate in the locus coeruleus and project widely throughout the cortex. Deficiency in this system contributes to fatigue, poor concentration, and psychomotor retardation.

By boosting both dopamine and norepinephrine, bupropion targets the "low energy, low motivation" cluster of depressive symptoms that SSRIs often fail to fully address.

Brain Regions Affected

Neuroimaging studies have shown that bupropion treatment modulates activity in several key brain regions:

- Amygdala — bupropion reduces overactivation of the amygdala in response to negative emotional stimuli, and this reduction correlates with clinical improvement

- Prefrontal cortex (including dorsomedial, ventromedial, and orbital frontal regions) — emotional reactivity in these areas decreases with treatment

- Anterior cingulate cortex — involved in mood regulation and error monitoring

- Nucleus accumbens — the brain's reward center, where bupropion enhances dopamine availability after chronic administration

- Insula and sensorimotor cortex — recent resting-state functional connectivity studies show bupropion alters connectivity patterns in these regions

Why Clinicians Like Bupropion

Bupropion has several advantages that make it a favorite among prescribers:

1. No sexual dysfunction — Unlike SSRIs, which cause sexual side effects in up to 70% of patients, bupropion has rates of sexual dysfunction below 1%. This alone makes it a game-changer for many patients.
2. Weight neutral to weight loss — While many antidepressants cause weight gain, bupropion is associated with modest weight loss, making it ideal for patients with weight concerns.
3. Energizing rather than sedating — Its mild stimulant-like properties help patients with fatigue, low motivation, and psychomotor slowing. It can also counteract SSRI-induced sedation when used as an adjunct.
4. Effective as monotherapy and as augmentation — Bupropion works well on its own and is one of the most commonly used augmentation agents when an SSRI alone isn't enough.
5. Low risk of QT prolongation — Bupropion carries the lowest risk of QT prolongation among antidepressants, making it a safer choice for patients with cardiac risk factors.
6. Versatility — From depression to smoking cessation to ADHD, it covers a lot of clinical ground.

Why Clinicians Are Cautious

No drug is perfect, and bupropion has its limitations:

1. Seizure risk — This is the most important safety concern. The risk is dose-related and increases significantly above 450 mg/day. Patients with seizure disorders, brain tumors, CNS infections, or conditions that lower the seizure threshold should not take bupropion.
2. Anxiety and agitation — Bupropion can worsen anxiety in some patients, particularly at higher doses. Its stimulating properties, while beneficial for some, can be counterproductive in patients with prominent anxiety.
3. Not ideal for anxiety disorders as monotherapy — Unlike SSRIs, bupropion does not have strong evidence for generalized anxiety disorder, panic disorder, or OCD.
4. Insomnia — The activating effects can disrupt sleep, which is why it should be taken in the morning.

Side Effects

Most common (≥5% and at least 2% more than placebo):

- Headache

- Dry mouth

- Nausea

- Insomnia

- Dizziness

- Constipation

- Agitation and anxiety

- Tremor

- Sweating

- Palpitations

- Tinnitus

Serious but less common:

- Seizures (dose-related)

- Hypertension (blood pressure should be monitored)

- Activation of mania/hypomania in patients with bipolar disorder

- Psychosis, hallucinations, paranoia (rare)

- Angle-closure glaucoma

- Hypersensitivity reactions

The Black Box Warning ⚠️

Like all antidepressants, bupropion carries an FDA Black Box Warning for suicidal thoughts and behaviors:

> Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in subjects over age 24; there was a reduction in risk with antidepressant use in subjects aged 65 and older.

What this means in practice:

- Monitor all patients closely when initiating therapy, especially those under 25

- Advise families and caregivers to watch for worsening depression, agitation, or emergence of suicidal ideation

- The warning applies to all antidepressants — it is not unique to bupropion

- The benefit of treating depression generally outweighs this risk, but vigilance is essential

Who Should NOT Take Bupropion?

Bupropion is contraindicated in the following situations:

- Seizure disorder — the most critical contraindication

- Current or prior diagnosis of anorexia nervosa or bulimia — higher incidence of seizures observed in these patients

- Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs — withdrawal states lower the seizure threshold

- Concurrent use of MAOIs — risk of hypertensive crisis; must allow a 14-day washout period

- Use of reversible MAOIs such as linezolid or IV methylene blue

- Known hypersensitivity to bupropion or its ingredients

Use with caution in patients with:

- Brain metastases or primary brain tumors

- Diabetes treated with insulin or oral hypoglycemics (hypoglycemia lowers seizure threshold)

- Heavy alcohol use

- Concomitant medications that lower seizure threshold (antipsychotics, tricyclics, theophylline, systemic corticosteroids)

- Hepatic or renal impairment (dose adjustment required)

Bupropion in Combination: The Power Couples

Bupropion is frequently combined with other medications to enhance efficacy:

Bupropion + SSRI (Augmentation for Treatment-Resistant Depression)

When an SSRI alone doesn't achieve remission, adding bupropion is one of the most common augmentation strategies. The combination broadens neurotransmitter coverage — serotonin from the SSRI, plus dopamine and norepinephrine from bupropion. This can also counteract SSRI-induced sexual dysfunction, weight gain, and fatigue.

Naltrexone + Bupropion (Contrave)

FDA-approved in 2014 for chronic weight management in adults with a BMI ≥30 (or ≥27 with comorbidities). Bupropion stimulates hypothalamic POMC neurons while naltrexone blocks opioid-mediated autoinhibition of those same neurons, creating a synergistic effect on appetite suppression and energy expenditure. Clinical trials showed approximately 5–6% total body weight loss at one year versus ~1% with placebo.

Bupropion + Nicotine Replacement Therapy

For smoking cessation, bupropion (as Zyban) can be combined with nicotine patches for enhanced quit rates.

Dosing at a Glance

Key dosing tips:

- Always titrate gradually to minimize seizure risk

- Take in the morning to avoid insomnia

- Swallow extended-release tablets whole — do not crush, chew, or divide

- Adjust dose for hepatic and renal impairment

The Bottom Line

Bupropion is a uniquely positioned antidepressant. In a landscape dominated by serotonin-focused medications, it offers a dopamine-and-norepinephrine alternative that addresses the motivational, energy, and pleasure deficits that many depressed patients struggle with most. Its favorable side effect profile — particularly the absence of sexual dysfunction and weight gain — makes it a first-line option for many patients and an invaluable augmentation tool for others.

It's not the right drug for everyone. Patients with seizure risk, eating disorders, or prominent anxiety may need a different approach. But for the right patient, bupropion can be transformative.

That's why it's our Drug of the Day.